Panitumumab: new drug. Metastatic colorectal cancer: don't make things worse!
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000556:secondary; D017277:Drug Approval; D004342:Drug Hypersensitivity; D066246:ErbB Receptors; D005060:Europe; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy; D000077544:Panitumumab; D016032:Randomized Controlled Trials as Topic; D012871:Skin Diseases / Q000139:chemically induced
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077544:Panitumumab; D066246:ErbB Receptors